Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Silent cardiac ischemia.

C Richard Conti1

  • 1Department of Cardiology, University of Florida College of Medicine, Gainesville, 32610, USA. CONTICR@medicine.ufl.edu

Current Opinion in Cardiology
|October 3, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obesity and Weight Loss.

European cardiology·2019
Same author

Non-PCI/CABG therapies for refractory angina.

Trends in cardiovascular medicine·2017
Same author

Prognostic Significance of Asymptomatic Myocardial Ischemia in Women vs. Men.

Current pharmaceutical design·2016
Same author

Coronary Artery Calcium Scanning: Past, Present, and Future.

JACC. Cardiovascular imaging·2016
Same author

Editorial Commentary: Statins and acute coronary syndromes.

Trends in cardiovascular medicine·2016
Same author

Ranolazine in Cardiac Arrhythmia.

Clinical cardiology·2015
Same journal

Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial.

Current opinion in cardiology·2026
Same journal

Advancements in wearable technology for heart failure patients.

Current opinion in cardiology·2026
Same journal

Minimally invasive approaches to coronary artery bypass grafting: techniques, current evidence, and future directions.

Current opinion in cardiology·2026
Same journal

Advances in artificial intelligence for the evaluation of mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Role of nutritional interventions to reduce cardiometabolic disease burden in the community.

Current opinion in cardiology·2026
Same journal

Artificial intelligence for right ventricular assessment: current evidence and future directions.

Current opinion in cardiology·2026
See all related articles

Treating asymptomatic patients with silent cardiac ischemia requires careful consideration of intervention risks versus benefits. The Asymptomatic Cardiac Ischemia Pilot (ACIP) Study offers insights into managing this "murky middle" group to prevent future cardiac events.

Area of Science:

  • Cardiology
  • Preventative Cardiovascular Medicine
  • Clinical Trial Research

Background:

  • A significant patient group exists with documented cardiac ischemia but no symptoms, posing treatment dilemmas.
  • The management of these asymptomatic patients, often termed the "murky middle," presents unique clinical challenges.
  • Defining the threshold for intervention based solely on test abnormalities is complex.

Purpose of the Study:

  • To explore the critical questions surrounding the treatment of patients with silent cardiac ischemia.
  • To evaluate the potential benefits and risks of intervening in asymptomatic individuals with documented ischemia.
  • To establish criteria for justifying interventions and measuring their efficacy in preventing future cardiac events.

Main Methods:

Related Experiment Videos

  • The article discusses insights derived from the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study.
  • Focuses on the decision-making process for treating silent ischemia.
  • Examines the justification of risks, costs, and inconvenience of interventions.
  • Main Results:

    • Intervention in asymptomatic patients is justifiable only if it demonstrably prevents future cardiac events.
    • The ACIP Study provides valuable data on the outcomes of managing silent ischemia.
    • Highlights the need for robust methods to measure intervention efficacy.

    Conclusions:

    • The management of silent cardiac ischemia serves as a crucial model for other preventative cardiovascular strategies.
    • Further research is needed to refine treatment guidelines for asymptomatic patients with ischemic heart disease.
    • Emphasizes a risk-benefit analysis for all interventions in this patient population.